Acadia Healthcare (ACHC) Projected to Announce Quarterly Earnings on Wednesday

Acadia Healthcare (NASDAQ:ACHC) is expected to be announcing its Q3 2026 results after the market closes on Wednesday, November 4th. Analysts expect the company to post earnings of $0.4625 per share and revenue of $877.76 million for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2026 earnings summary page for the latest details on the call scheduled for Thursday, November 5, 2026 at 9:00 AM ET.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, beating analysts’ consensus estimates of $0.35 by $0.03. The firm had revenue of $865.84 million for the quarter, compared to analysts’ expectations of $844.19 million. During the same quarter in the previous year, the business earned $0.83 EPS. The company’s revenue for the quarter was down .4% on a year-over-year basis. On average, analysts expect Acadia Healthcare to post $1.55 EPS for the current fiscal year and $1.78 EPS for the next fiscal year.

Acadia Healthcare Price Performance

ACHC stock opened at $29.74 on Wednesday. The firm has a fifty day moving average price of $28.94 and a 200 day moving average price of $25.39. Acadia Healthcare has a fifty-two week low of $11.43 and a fifty-two week high of $35.83.

Analyst Upgrades and Downgrades

A number of research analysts have commented on the stock. UBS Group raised their target price on shares of Acadia Healthcare from $31.00 to $39.00 and gave the company a “buy” rating in a research report on Thursday, July 9th. Leerink Partners raised their price target on shares of Acadia Healthcare from $30.00 to $33.00 and gave the stock a “market perform” rating in a report on Wednesday, September 23rd. Guggenheim lifted their price objective on shares of Acadia Healthcare from $38.00 to $39.00 and gave the company a “buy” rating in a research note on Thursday, July 30th. Cantor Fitzgerald restated a “neutral” rating on shares of Acadia Healthcare in a research note on Tuesday, October 6th. Finally, TD Cowen raised their price target on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, July 14th. Eight investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $30.69.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc is a provider of behavioral healthcare services headquartered in Franklin, Tennessee. The company operates psychiatric hospitals, specialty treatment facilities and outpatient programs focused on mental health and substance use disorders.

Acadia’s services include inpatient and outpatient psychiatric care, addiction treatment, residential treatment, eating-disorder programs, and services for children and adolescents. Its facilities serve patients with a range of behavioral health conditions, including depression, anxiety, trauma-related disorders and substance use disorders.

Founded in 2005, Acadia operates primarily in the United States and also has a significant presence in the United Kingdom through its ownership of Priory, a behavioral healthcare provider.